Biomedical Catalyst 2019 round 1: feasibility and primer awards

The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. This competition combines the feasibility and primer (proof of concept) strands to enable SMEs to apply for projects lasting 3 to 18 months.

The aim of this competition is to explore and evaluate the commercial potential of an innovative scientific idea or carry out a technical evaluation through to proof of concept in a model system by:

• reviewing research evidence and identifying possible applications
• assessing business opportunities
• assessing and/or protecting intellectual property
• validating initial concepts and existing pre-clinical work through experimental studies
• initial demonstration using in-vitro and in-vivo models (but not human clinical trials such as safety and efficacy)
• early stage prototyping
• preliminary regulatory advice

Summary:

Competition opens : 21 January 2019 (Monday)

Competition closes : 3 April 2019 (12 noon; Wednesday)

Available funding : between £50,000 and £1,000,000

Duration : between 3 to 18 months (starts by 1 September 2019; ends by 31 March 2021)

Please this link for more details.

Biomedical Catalyst 2019 round 1: early and late stage awards

UK businesses can apply for a share of up to £7 million to explore and evaluate the commercial potential of a scientific idea to solve a healthcare challenge.

The aim of this competition is to enable companies to create a data package that can support the subsequent testing of your products or carry out evaluations in a clinical setting or other relevant environment. This can include:

• experimental evaluation (at laboratory scale)
• use of in vitro and in vivo models to evaluate proof of concept or safety
• exploring potential production mechanisms
• prototyping
• product development planning
• intellectual property protection
• demonstrating of clinical utility and effectiveness
• demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
• regulatory planning

Summary:

Competition opens : 21 January 2019 (Monday)

Competition closes : 3 April 2019 (12 noon; Wednesday)

Available funding : between £250,000 and £4,000,000

Duration : Must be at least one year (starts by 1 September 2019; ends by 31 March 2021)

Please this link for more details.